Accord Animal Health has launched Dexmedocord in the UK, giving veterinary practices a new dexmedetomidine injection option for dogs and cats that the company says is competitively priced and supported by commercial rebates.

Dexmedocord is a dexmedetomidine 0.5 mg/ml solution for injection for dogs and cats and is available through all major UK veterinary wholesalers.

It is indicated in cats and dogs for non-invasive, mildly to moderately painful procedures and examinations requiring restraint, sedation and analgesia.

In dogs, it is also indicated for deep sedation and analgesia in concomitant use with butorphanol for medical and minor surgical procedures, and as a premedication in dogs and cats before induction and maintenance of general anaesthesia.

Dexmedetomidine is the active dextrorotatory enantiomer of medetomidine.

Bob Ferguson, Director of Animal Health at Accord Animal Health, said: "Veterinary practices need trusted products backed by accessible pricing and reliable supply."

"Dexmedocord marks an important milestone as our first POM-V pharmaceutical launch in the UK and reflects the established expertise and strong heritage in high-quality pharmaceuticals that we bring through the wider Accord group."

accordanimalhealth.com